Conmed Corp (CNMD)

R&D to Revenue

4.51%

Quarterly · Period ending:

CNMD logo

CNMD R&D to Revenue

Latest reported4.51%
CNMD Quarterly R&D/Revenue (0.00% → 4.51%)
High-resolution chart · PNG

CNMD r&d to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Conmed Corp R&D to Revenue — Quarterly
Period endingR&D to Revenue
4.5125%
5.1516%
3.9893%
4.1057%
4.1214%
4.0535%
3.8087%
4.281%
4.2451%
4.3532%
4.2893%
4.0922%
4.2726%
4.2438%
4.8711%
4.6411%
4.1463%
4.404%
4.1472%
4.3641%
4.4356%
4.3094%
4.6344%
4.1777%
5.5138%
4.7288%
4.5661%
4.7027%
4.955%
4.8425%
4.2777%
6.9805%
4.6918%
3.8161%
3.7645%
4.35%
4.0785%
4.0833%
3.7404%
4.5202%
4.1405%
4.5574%
3.529%
3.9318%
4.1436%
3.6765%
3.6725%
3.9798%
3.6695%
3.8263%
3.1886%
3.9971%
3.4402%
3.0706%
3.4038%
3.8909%
3.7913%
3.6513%
3.8539%
4.0627%
3.7094%
4.187%
4.4166%
4.2969%
3.5569%
4.3557%
4.3261%
4.3909%
4.4942%
5.1743%
4.2807%
4.8314%
4.5078%
4.2344%
3.9126%
4.8258%
4.4033%
4.4406%
4.7854%
4.6857%
4.5867%
4.938%
4.4621%
4.2735%
4.0278%
3.7528%
3.6744%
3.5574%
3.6941%
3.5375%
3.5409%
3.716%
3.5153%
3.1372%
3.4115%
3.7527%
3.665%
3.3779%
3.6771%
3.3147%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.